Cargando…
Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF
BACKGROUND: Tuberculosis (TB) represents the ninth leading cause of death worldwide. In 2016 are estimated 1.3 million TB deaths among HIV negative people and an additional 374,000 deaths among HIV positive people. In 2016 are estimated 1.4 million new cases of TB in people living with HIV (PLHIV),...
Autores principales: | Orlando, S., Triulzi, I., Ciccacci, F., Palla, I., Palombi, L., Marazzi, M. C., Giuliano, M., Floridia, M., Mancinelli, S., Mutemba, E., Turchetti, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053163/ https://www.ncbi.nlm.nih.gov/pubmed/30024890 http://dx.doi.org/10.1371/journal.pone.0200523 |
Ejemplares similares
-
Contribution of Xpert(®) MTB/RIF to pediatric TB diagnosis in Mozambique
por: Mutemba, C. M., et al.
Publicado: (2023) -
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF
por: Lombardi, Giulia, et al.
Publicado: (2017) -
Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013) -
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019) -
Diagnostic Accuracy of Xpert MTB/RIF in Sputum Smear-Negative Pulmonary Tuberculosis
por: Rasheed, Waqas, et al.
Publicado: (2019)